Table 2. Enriched canonical pathways in ACSL4-overexpressing MCF-7 cells.
Ingenuity Canonical Pathways | −log(p-value) |
---|---|
EIF2 Signaling | 21.2 |
Protein Ubiquitination Pathway | 14.6 |
Regulation of eIF4 and p70S6K Signaling | 8.88 |
Molecular Mechanisms of Cancer | 8.26 |
mTOR Signaling | 8.18 |
Mitochondrial Dysfunction | 7.47 |
NRF2-mediated Oxidative Stress Response | 6.88 |
Cell Cycle: G1/S Checkpoint Regulation | 6.81 |
ATM Signaling | 6.81 |
Hypoxia Signaling in the Cardiovascular System | 6.67 |
Oxidative Phosphorylation | 6.25 |
PI3K/AKT Signaling | 6.19 |
14–3-3-mediated Signaling | 5.72 |
NGF Signaling | 5.50 |
PTEN Signaling | 5.14 |
Antiproliferative Role of TOB in T Cell Signaling | 5.12 |
Pancreatic Adenocarcinoma Signaling | 4.94 |
D-myo-inositol (1,3,4)-trisphosphate Biosynthesis | 4.76 |
ERK5 Signaling | 4.66 |
Type II Diabetes Mellitus Signaling | 4.66 |
Hereditary Breast Cancer Signaling | 4.55 |
TGF-β Signaling | 4.55 |
IPA analysis of RNA-Seq data towards canonical pathways. Pathways are shown which were designated significantly enriched by the software, with a p-value < 0.05 by Fisher's Exact test.